WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS

This group comprises plain and combined preparations used in the treatment of cerebrovascular or peripheral circulatory disorders.
Combinations with Antihypertensives, see C02 - Antihypertensives.
Combinations with vasodilators used in cardiac diseases, see C01DA.

The DDDs are based on the doses used for the treatment of cerebral and peripheral vascular disorders.


C04AE Ergot alkaloids

Includes combinations with other peripheral vasodilators.
Combinations with calcium channel blockers are classified in C08CA.
Combinations of cinnarizine and dihydroergcristine are classified in N07CA52.
See also G02AB and N02CA.


List of abbreviations

Last updated: 2020-12-17